Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

VetMed Pharm12

Haemostasis Pharmacology

QuestionAnswer
Heparin MOA binds to plasma anti-thrombin III --> forms AT-III-heparin-thrombin complex inhibits biochemical activity of thrombin suppresses thrombin-mediated fibrinogen suppresses other coagulation factors suppresses normal platelet function
Danaparoid MOA anti-thrombin III inhibition of factor Xa tx deep-vein thrombosis
Streptokinase MOA promotes generation of active plasmin
Anti-platelet Therapy facilitates endothelial repair at sites of vascular injury
Arterial vs. Venous Thrombosis arterial - >platelets venous - >fibrin
Multiple Clinical Conditions RxTx by Heparin DIC vascular thrombosis septic pleuritis and peritonitis hypercoag states - nephritic syndrome, cushing's, cardiomyopathy angina & myocardial infarction, cardiac bypass (humans) lipemia conditions r
Molecular Disadvantages of Excessively High Doses of Aspirin in Tx DIC/Arterial Thrombosis inhibits biochem activity of platelet thromboxane synthesis and vascular endothelial PGI2 --> exacerbates hypercoag disorders
Heparin Therapy Sequelae increased hemorrhagic tendencies premature/accelerated removal of RBCs (EV hemolysis)
NSAIDs Therapy Sequelae inhibits biochem activity of platelet thromboxane synthesis and vascular endothelial PGI2 --> exacerbates hypercoag disorders
Coag Factors Inhibited by Heparin IIa IXa Xa Xia thrombin anti-thrombin III
Antidote for Heparin Therapy protamine sulfate
RxTx to Dx Certain Coag Factor Deficiencies aspirin
Precautions to Admin of Whole Blood, Plasma, Platelet-Enriched Plasma tx primary dz state cross-match donor and recipient simultaneous tx with anti-coag and/or anti-platelet therapy
Created by: 26509889